-
#AANAM – Reldesemtiv Reduces ALS Progression and Lung Function Decline, Study Shows
Cytokinetics’ reldesemtiv reduced lung function decline and overall disease progression in people with amyotrophic lateral sclerosis in a Phase 2 trial. Read more about reldesemtiv here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.